List of Tables
Table 1. Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Asthma
Table 3. Key Players of Chronic Obstructive Pulmonary Disease (COPD)
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other Diseases
Table 6. Global Drug Treatment for Respiratory Disease Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Drug Treatment for Respiratory Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Drug Treatment for Respiratory Disease Market Size by Region (US$ Million), 2021–2026
Table 9. Global Drug Treatment for Respiratory Disease Market Share by Region (2021–2026)
Table 10. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Drug Treatment for Respiratory Disease Market Share by Region (2027–2032)
Table 12. Drug Treatment for Respiratory Disease Market Trends
Table 13. Drug Treatment for Respiratory Disease Market Drivers
Table 14. Drug Treatment for Respiratory Disease Market Challenges
Table 15. Drug Treatment for Respiratory Disease Market Restraints
Table 16. Global Drug Treatment for Respiratory Disease Revenue by Players (US$ Million), 2021–2026
Table 17. Global Drug Treatment for Respiratory Disease Market Share by Players (2021–2026)
Table 18. Global Top Drug Treatment for Respiratory Disease Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drug Treatment for Respiratory Disease Revenue, 2025
Table 19. Ranking of Global Top Drug Treatment for Respiratory Disease Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Drug Treatment for Respiratory Disease Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Drug Treatment for Respiratory Disease, Headquarters and Area Served
Table 22. Global Key Players of Drug Treatment for Respiratory Disease, Products and Applications
Table 23. Global Key Players of Drug Treatment for Respiratory Disease, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Drug Treatment for Respiratory Disease Market Size by Type (US$ Million), 2021–2026
Table 26. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2021–2026)
Table 27. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2027–2032)
Table 29. Global Drug Treatment for Respiratory Disease Market Size by Application (US$ Million), 2021–2026
Table 30. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2021–2026)
Table 31. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2027–2032)
Table 33. North America Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Drug Treatment for Respiratory Disease Market Size by Country (US$ Million), 2021–2026
Table 35. North America Drug Treatment for Respiratory Disease Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Drug Treatment for Respiratory Disease Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Drug Treatment for Respiratory Disease Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Drug Treatment for Respiratory Disease Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Drug Treatment for Respiratory Disease Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Drug Treatment for Respiratory Disease Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (US$ Million), 2027–2032
Table 48. GSK Company Details
Table 49. GSK Business Overview
Table 50. GSK Drug Treatment for Respiratory Disease Product
Table 51. GSK Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 52. GSK Recent Development
Table 53. AstraZeneca Company Details
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Drug Treatment for Respiratory Disease Product
Table 56. AstraZeneca Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 57. AstraZeneca Recent Development
Table 58. Boehringer Ingelheim Company Details
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Drug Treatment for Respiratory Disease Product
Table 61. Boehringer Ingelheim Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 62. Boehringer Ingelheim Recent Development
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Drug Treatment for Respiratory Disease Product
Table 66. Novartis Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 67. Novartis Recent Development
Table 68. Mylan Company Details
Table 69. Mylan Business Overview
Table 70. Mylan Drug Treatment for Respiratory Disease Product
Table 71. Mylan Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 72. Mylan Recent Development
Table 73. Vertex Pharmaceuticals Company Details
Table 74. Vertex Pharmaceuticals Business Overview
Table 75. Vertex Pharmaceuticals Drug Treatment for Respiratory Disease Product
Table 76. Vertex Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 77. Vertex Pharmaceuticals Recent Development
Table 78. F. Hoffman La Roche Company Details
Table 79. F. Hoffman La Roche Business Overview
Table 80. F. Hoffman La Roche Drug Treatment for Respiratory Disease Product
Table 81. F. Hoffman La Roche Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 82. F. Hoffman La Roche Recent Development
Table 83. Teva Pharmaceuticals Company Details
Table 84. Teva Pharmaceuticals Business Overview
Table 85. Teva Pharmaceuticals Drug Treatment for Respiratory Disease Product
Table 86. Teva Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 87. Teva Pharmaceuticals Recent Development
Table 88. Cipla Company Details
Table 89. Cipla Business Overview
Table 90. Cipla Drug Treatment for Respiratory Disease Product
Table 91. Cipla Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 92. Cipla Recent Development
Table 93. Fibrogen Company Details
Table 94. Fibrogen Business Overview
Table 95. Fibrogen Drug Treatment for Respiratory Disease Product
Table 96. Fibrogen Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 97. Fibrogen Recent Development
Table 98. Liminal Biosciences Company Details
Table 99. Liminal Biosciences Business Overview
Table 100. Liminal Biosciences Drug Treatment for Respiratory Disease Product
Table 101. Liminal Biosciences Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 102. Liminal Biosciences Recent Development
Table 103. PharmAkea Therapeutics Company Details
Table 104. PharmAkea Therapeutics Business Overview
Table 105. PharmAkea Therapeutics Drug Treatment for Respiratory Disease Product
Table 106. PharmAkea Therapeutics Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 107. PharmAkea Therapeutics Recent Development
Table 108. IQVIA Company Details
Table 109. IQVIA Business Overview
Table 110. IQVIA Drug Treatment for Respiratory Disease Product
Table 111. IQVIA Revenue in Drug Treatment for Respiratory Disease Business (US$ Million), 2021–2026
Table 112. IQVIA Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Drug Treatment for Respiratory Disease Picture
Figure 2. Global Drug Treatment for Respiratory Disease Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Drug Treatment for Respiratory Disease Market Share by Type: 2025 vs 2032
Figure 4. Asthma Features
Figure 5. Chronic Obstructive Pulmonary Disease (COPD) Features
Figure 6. Lung Cancer Features
Figure 7. Other Diseases Features
Figure 8. Global Drug Treatment for Respiratory Disease Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Drug Treatment for Respiratory Disease Market Share by Application: 2025 vs 2032
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Drug Treatment for Respiratory Disease Report Years Considered
Figure 14. Global Drug Treatment for Respiratory Disease Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Drug Treatment for Respiratory Disease Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Drug Treatment for Respiratory Disease Market Share by Region: 2025 vs 2032
Figure 17. Global Drug Treatment for Respiratory Disease Market Share by Players in 2025
Figure 18. Global Drug Treatment for Respiratory Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Drug Treatment for Respiratory Disease Revenue in 2025
Figure 20. North America Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Drug Treatment for Respiratory Disease Market Share by Country (2021–2032)
Figure 22. United States Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Drug Treatment for Respiratory Disease Market Share by Country (2021–2032)
Figure 26. Germany Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Drug Treatment for Respiratory Disease Market Share by Region (2021–2032)
Figure 34. China Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Drug Treatment for Respiratory Disease Market Share by Country (2021–2032)
Figure 42. Mexico Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Drug Treatment for Respiratory Disease Market Share by Country (2021–2032)
Figure 46. Israel Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Drug Treatment for Respiratory Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. GSK Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 50. AstraZeneca Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 52. Novartis Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 53. Mylan Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 54. Vertex Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 55. F. Hoffman La Roche Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 56. Teva Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 57. Cipla Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 58. Fibrogen Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 59. Liminal Biosciences Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 60. PharmAkea Therapeutics Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 61. IQVIA Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
